Literature DB >> 18437571

The bile acid turnover rate assessed with the (75)SeHCAT test is stable in chronic diarrhoea but slightly decreased in healthy subjects after a long period of time.

Antal Bajor1, Anders Kilander, Henrik Sjövall, Mats Rudling, Kjell-Arne Ung.   

Abstract

The stability of bile acid turnover rate was evaluated retrospectively using repeat SeHCAT tests in patients with chronic diarrhoea and prospectively for 16 years in healthy subjects. The SeHCAT values were stable in 39 patients with chronic diarrhoea, as shown by a comparison of the test results [data presented as median and (25th-75th percentile)]: 18% (8-23) in the first test versus 14% (9-21) in the second test [n = 39, P = 0.37, time interval 44 months (16-68), repeatability index >95%]. In contrast, they were reduced after 16 years in healthy subjects: 38% (30-49.5) in the first test versus 31% (21-49.5) in the second test (P < 0.03). In healthy subjects, the body mass index increased by 13% from 23.2 kg/m(2) (21-24.6) to 26.2 kg/m(2) (22.5-27.8) (P < 0.01) during the 16 years. There was a negative correlation between hepatic bile acid synthesis and the SeHCAT values (r = -0.615, P = 0.02, n = 14). In conclusion, the turnover rate of bile acids is stable over a long period of time in patients with chronic diarrhoea irrespective of bile acid malabsorption, suggesting that a repeat SeHCAT test is dispensable. There is a significant negative correlation between bile acid synthesis and SeHCAT test results in healthy subjects. The SeHCAT test values are slightly reduced in healthy subjects after 16 years.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437571     DOI: 10.1007/s10620-008-0256-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Impact of bile acid malabsorption on steatorrhoea and symptoms in patients with chronic diarrhoea.

Authors:  K A Ung; A F Kilander; A Lindgren; H Abrahamsson
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 2.566

2.  Use of a gamma-labeled bile acid (75SeHCAT) as a test of ileal function. Methods of improving accuracy.

Authors:  R Ferraris; R Jazrawi; C Bridges; T C Northfield
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Prognosis of adult-onset idiopathic bile acid malabsorption.

Authors:  P Rössel; H Sortsøe Jensen; P Qvist; A Arveschoug
Journal:  Scand J Gastroenterol       Date:  1999-06       Impact factor: 2.423

5.  Experience with a gastrointestinal marker (51CrCl3) in a combined study of ileal function using 75SeHCAT and 58CoB12 measured by whole body counting.

Authors:  T Smith; I Bjarnason
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

6.  In vitro determination of active bile acid absorption in small biopsy specimens obtained endoscopically or surgically from the human intestine.

Authors:  K-A Ung; G Olofsson; A Fae; A Kilander; C Ohlsson; O Jonsson
Journal:  Eur J Clin Invest       Date:  2002-02       Impact factor: 4.686

7.  Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue.

Authors:  E H Thaysen; M Orholm; T Arnfred; J Carl; P Rødbro
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

8.  Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT).

Authors:  M V Merrick; M A Eastwood; J R Anderson; H M Ross
Journal:  J Nucl Med       Date:  1982-02       Impact factor: 10.057

9.  Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood.

Authors:  Cecilia Gälman; Ingela Arvidsson; Bo Angelin; Mats Rudling
Journal:  J Lipid Res       Date:  2003-01-16       Impact factor: 5.922

10.  Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function.

Authors:  H Nyhlin; G Brydon; A Danielsson; S Westman
Journal:  Hepatogastroenterology       Date:  1984-08
View more
  6 in total

Review 1.  New insights into bile acid malabsorption.

Authors:  Ian Johnston; Jonathan Nolan; Sanjeev S Pattni; Julian R F Walters
Journal:  Curr Gastroenterol Rep       Date:  2011-10

2.  Outcomes from treating bile acid malabsorption using a multidisciplinary approach.

Authors:  Ankur Gupta; Ann C Muls; Amyn Lalji; Karen Thomas; Lorraine Watson; Clare Shaw; H Jervoise N Andreyev
Journal:  Support Care Cancer       Date:  2015-02-20       Impact factor: 3.603

Review 3.  Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.

Authors:  Alan N Barkun; Jonathan Love; Michael Gould; Henryk Pluta; Hillary Steinhart
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

4.  What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea?

Authors:  Darren C R Fernandes; Dennis Poon; Laura L White; H Jervoise N Andreyev
Journal:  Frontline Gastroenterol       Date:  2018-07-26

5.  Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.

Authors:  Sanjeev S Pattni; W Gordon Brydon; Tracy Dew; Julian R F Walters
Journal:  Clin Transl Gastroenterol       Date:  2012-07-26       Impact factor: 4.488

6.  Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study.

Authors:  Virginia Flores; Helena Martínez-Lozano; Federico Bighelli; Javier Orcajo; Javier García-Lledó; Juan Carlos Alonso-Farto; Luis Menchén
Journal:  BMC Gastroenterol       Date:  2021-02-09       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.